Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00304915 · ClinicalTrials.gov registry record · NA

HIV Translating Initiatives for Depression Into Effective Solutions

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
249
Enrollment target

NCT00304915: Completed NA study, sponsored by VA Office of Research and Development.

NCT00304915 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 249 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00304915, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
249 participants
Enrollment target

Study Summary

This study is a randomized trial designed to test and refine a collaborative care model for treating depression in VA patients with HIV.

Primary Outcome

Depression symptom severity over the past two weeks was measured using the Hopkins Symptom Checklist (SCL-20). The SCL-20 includes the 13-item depression scale plus 7 depression-related items from the Hopkins Symptom Checklist-90-Revised. The items are scored from 0 to 4 and averaged to provide a mean depression severity score from 0 to 4. Depression treatment response at 6-months was defined as a 50% decrease in mean SCL-20 score compared to baseline.

Interventions

  • BEHAVIORAL Collaborative Care Interventions

Trial Details

FieldValue
Enrollment Target 249 participants
Start Date 2007-02
Est. Completion 2016-11
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT00304915 record still lists

NCT00304915 is an interventional study that assigns participants to a tested intervention. The registered 249 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 1 intervention - of which Collaborative Care Interventions is the first listed.

NCT00304915 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00304915 about?

NCT00304915 is a clinical study titled "HIV Translating Initiatives for Depression Into Effective Solutions". This study is a randomized trial designed to test and refine a collaborative care model for treating depression in VA patients with HIV.

What is the current status of trial NCT00304915?

This trial is currently completed. It is a NA study. The enrollment target is 249 participants. The study started on 2007-02. Estimated completion is 2016-11.

What interventions are being tested in trial NCT00304915?

The interventions under investigation include: Collaborative Care Interventions (BEHAVIORAL).

Who is sponsoring clinical trial NCT00304915?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00304915's enrollment target sits among peer trials

249 434th of 2000 higher than 1,567 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04628767 · 249 participants · Phase 2

    Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

  • NCT05834907 · 249 participants · NA

    Hands and Hearts Together

  • NCT06067555 · 249 participants · Early Phase 1

    Intradermal Influenza Vaccination

  • NCT06588478 · 249 participants · Phase 2

    A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00304915, the US trial registry maintained by the National Library of Medicine. NCT00304915 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.